Vectorite Biomedical Inc. (TPEX:4170)

Market Cap	525.25M -14.3%
Revenue (ttm)	54.81M -19.3%
Net Income	118.22M
EPS	2.69
Shares Out	43.77M
PE Ratio	4.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30
Open	12.00
Previous Close	12.00
Day's Range	12.00 - 12.00
52-Week Range	11.40 - 18.15
Beta	0.49
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Vectorite Biomedical

Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally. The company is involved in cell preparation product manufacturing; and collection and storage of immune cells. Its products are used in the field of infectious diseases and inflammation, cancer, and oncology. The company was incorporated in 2004 and is based in New Taipei City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4170

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error